|
|
 |
|
Total Number of Holdings (excluding cash): 36
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
Medical Equipment and Services |
497 |
$250,512.85 |
9.40% |
| DexCom, Inc. |
DXCM |
252131107 |
Medical Equipment and Services |
3,124 |
$228,301.92 |
8.56% |
| ResMed Inc. |
RMD |
761152107 |
Medical Equipment and Services |
857 |
$222,065.84 |
8.33% |
| IQVIA Holdings Inc. |
IQV |
46266C105 |
Health Care Providers |
1,233 |
$204,209.46 |
7.66% |
| Guardant Health, Inc. |
GH |
40131M109 |
Pharmaceuticals and Biotechnology |
1,630 |
$168,053.00 |
6.30% |
| Align Technology, Inc. |
ALGN |
016255101 |
Medical Equipment and Services |
829 |
$157,526.58 |
5.91% |
| Veeva Systems Inc. (Class A) |
VEEV |
922475108 |
Health Care Providers |
874 |
$157,590.94 |
5.91% |
| Natera, Inc. |
NTRA |
632307104 |
Medical Equipment and Services |
699 |
$148,271.88 |
5.56% |
| Illumina, Inc. |
ILMN |
452327109 |
Pharmaceuticals and Biotechnology |
1,177 |
$138,497.59 |
5.20% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
Medical Equipment and Services |
1,437 |
$130,177.83 |
4.88% |
| QIAGEN N.V. |
QGEN |
N72482156 |
Medical Equipment and Services |
2,526 |
$122,687.81 |
4.60% |
| Masimo Corporation |
MASI |
574795100 |
Medical Equipment and Services |
549 |
$96,129.90 |
3.61% |
| Insulet Corporation |
PODD |
45784P101 |
Medical Equipment and Services |
346 |
$83,693.94 |
3.14% |
| iRhythm Holdings, Inc. |
IRTC |
450056106 |
Medical Equipment and Services |
325 |
$49,062.00 |
1.84% |
| TransMedics Group, Inc. |
TMDX |
89377M109 |
Medical Equipment and Services |
329 |
$44,168.25 |
1.66% |
| Doximity, Inc. (Class A) |
DOCS |
26622P107 |
Health Care Providers |
1,570 |
$40,113.50 |
1.50% |
| Hims & Hers Health, Inc. |
HIMS |
433000106 |
Health Care Providers |
2,472 |
$38,637.36 |
1.45% |
| Oscar Health, Inc. (Class A) |
OSCR |
687793109 |
Life Insurance |
2,776 |
$36,726.48 |
1.38% |
| Establishment Labs Holdings Inc. |
ESTA |
G31249108 |
Medical Equipment and Services |
408 |
$31,008.00 |
1.16% |
| Adaptive Biotechnologies Corporation |
ADPT |
00650F109 |
Pharmaceuticals and Biotechnology |
2,013 |
$30,597.60 |
1.15% |
| Twist Bioscience Corporation |
TWST |
90184D100 |
Pharmaceuticals and Biotechnology |
592 |
$28,765.28 |
1.08% |
| Veracyte, Inc. |
VCYT |
92337F107 |
Pharmaceuticals and Biotechnology |
795 |
$28,325.85 |
1.06% |
| Privia Health Group, Inc. |
PRVA |
74276R102 |
Health Care Providers |
1,203 |
$26,453.97 |
0.99% |
| Alphatec Holdings, Inc. |
ATEC |
02081G201 |
Medical Equipment and Services |
2,003 |
$26,059.03 |
0.98% |
| 10X Genomics, Inc. (Class A) |
TXG |
88025U109 |
Pharmaceuticals and Biotechnology |
1,139 |
$21,504.32 |
0.81% |
| Tandem Diabetes Care, Inc. |
TNDM |
875372203 |
Medical Equipment and Services |
788 |
$19,361.16 |
0.73% |
| LifeStance Health Group, Inc. |
LFST |
53228F101 |
Health Care Providers |
2,541 |
$18,168.15 |
0.68% |
| Inspire Medical Systems, Inc. |
INSP |
457730109 |
Medical Equipment and Services |
290 |
$17,263.70 |
0.65% |
| PROCEPT BioRobotics Corporation |
PRCT |
74276L105 |
Medical Equipment and Services |
606 |
$16,525.62 |
0.62% |
| Progyny, Inc. |
PGNY |
74340E103 |
Health Care Providers |
762 |
$15,986.76 |
0.60% |
| NeoGenomics, Inc. |
NEO |
64049M209 |
Medical Equipment and Services |
1,507 |
$14,904.23 |
0.56% |
| QuidelOrtho Corporation |
QDEL |
219798105 |
Medical Equipment and Services |
613 |
$13,780.24 |
0.52% |
| Teladoc Health, Inc. |
TDOC |
87918A105 |
Health Care Providers |
2,226 |
$10,551.24 |
0.40% |
| Hinge Health, Inc. (Class A) |
HNGE |
433313103 |
Health Care Providers |
224 |
$9,253.44 |
0.35% |
| Beta Bionics, Inc. |
BBNX |
08659B102 |
Medical Equipment and Services |
620 |
$8,494.00 |
0.32% |
| Schrodinger, Inc. |
SDGR |
80810D103 |
Software and Computer Services |
662 |
$7,632.86 |
0.29% |
| US Dollar |
$USD |
|
Other |
4,511 |
$4,511.18 |
0.17% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|